XFOR icon

X4 Pharmaceuticals

53 hedge funds and large institutions have $69.3M invested in X4 Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 8 closing their positions.

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
4
Increased
18
Reduced
18
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$11.2M 1,648,485
O
2
OrbiMed
New York
$7.36M 1,086,493
BlackRock
3
BlackRock
New York
$6.68M 986,193 +13,155 +1%
BI
4
BVF Inc
California
$5.37M 792,892 -218,000 -22%
IC
5
Ikarian Capital
Texas
$4.91M 724,680 +719,680 +14,394%
Vanguard Group
6
Vanguard Group
Pennsylvania
$4.86M 717,392 -3,233 -0.4%
RCM
7
RA Capital Management
Massachusetts
$3.79M 559,494
Axa
8
Axa
France
$3.7M 546,078 +24,544 +5%
State Street
9
State Street
Massachusetts
$2.86M 423,086 +2,800 +0.7%
NLVP
10
New Leaf Venture Partners
New York
$2.27M 335,000
PVMCV
11
Polaris Venture Management Co V
Massachusetts
$2.11M 311,492
SHI
12
SV Health Investors
Massachusetts
$2.11M 311,490
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.65M 242,988 +15,016 +7%
Northern Trust
14
Northern Trust
Illinois
$1.57M 231,035 -9,910 -4%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$1.5M 221,912 -475,888 -68%
Renaissance Technologies
16
Renaissance Technologies
New York
$1.06M 156,044 +53,200 +52%
Nuveen Asset Management
17
Nuveen Asset Management
Illinois
$562K 83,096 +403 +0.5%
BFM
18
Boothbay Fund Management
New York
$520K 76,765 +76,765 New
OM
19
Opaleye Management
Massachusetts
$508K 75,000 +75,000 New
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$456K 67,423
PAM
21
Panagora Asset Management
Massachusetts
$455K 67,197 +15,380 +30%
ZIM
22
Zacks Investment Management
Illinois
$379K 55,931 -20,183 -27%
Goldman Sachs
23
Goldman Sachs
New York
$348K 51,418 +19,835 +63%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$333K 49,153 +1,252 +3%
CAM
25
ClariVest Asset Management
California
$309K 45,700 +6,200 +16%